LIPO (lipella.com) Bozor qiymatining balans qiymatiga nisbati

Lipella Pharmaceuticals Inc (LIPO) kompaniyasining rasmiy ramzlari

Qovuq terapiyasi usullarini ishlab chiqish Lipella Pharmaceuticals (LIPO) kompaniyasi uchun uning dori vositalariga barqaror talabni va'da qilmoqda. Buxgalteriya qiymatiga nisbatan narx tarixiy ko'rsatkichlari ushbu salohiyatni vizuallashtiradi, bunda joriy daraja 0.53 ni tashkil etadi. Liposomal yallig'lanishga qarshi agentlarning mahalliy yetkazib berishidagi innovatsiyalar biznes asosini shakllantiradi, tajribali test yechimlari partiyalari esa ishonchli shartnomaviy hamkorlar orqali ishlab chiqariladi.

LIPO Lipella Pharma: Balans qiymatiga nisbatan bozor qiymati 28.04.2023 - 19.07.2025 oraligʻida

Lipella Pharmaceuticals Inc (LIPO) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Lipella Pharmaceuticals|LIPO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Lipella|LIPO - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Lipella Pharmaceuticals|LIPO - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati lipella.com|LIPO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Lipella Pharmaceuticals|LIPO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Lipella|LIPO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Lipella|LIPO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Lipella Pharmaceuticals
Kompaniyaning dastlabki tahlili:Lipella Pharmaceuticals - LIPO
Lipella original mahsuloti

Ushbu koeffitsient biznesning bozor qiymati va uning sof aktivlari qiymati o'rtasidagi bog'liqlikni aks ettiradi. Bozor qiymatining balans qiymatiga nisbati koeffitsiyenti tarixini tahlil qilish orqali investor aktivlar ustidan nazorat uchun to'lanadigan premiumni baholaydi. Hisob-kitob bozor bahosini balans kapitaliga bo'lishga asoslangan. Lipella Pharmaceuticals (LIPO) uchun ushbu ko'rsatkich LP-10 dori vositasining istiqbollariga nisbatan aktivlarning qanchalik past baholanganlik darajasini ko'rsatadi. Saratonni davolashdagi potensialga qaramay, bu yerdagi past qiymatlar xatarlarni yashirishi mumkin.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati HLN|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|Bozor qiymatining balans qiymatiga nisbati MindWalk Holdings Inc. HYFT|Bozor qiymatining balans qiymatiga nisbati ABVC BioPharma Inc. ABVC|Bozor kapitallashuvining balans qiymatiga nisbati CPIX (Cumberland Pharma)|QNTM: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati FibroGen, Inc. (FGEN)|telomirpharma.com (TELO) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati RANI (Rani Therapeutics Holdings)|Bozor qiymatining balans qiymatiga koeffitsiyenti SNYR|Bozor qiymatining balans qiymatiga nisbati Rallybio Corporation (RLYB)|Bozor qiymatining balans qiymatiga nisbati LEXX (lexariabioscience.com)|Bozor qiymatining balans qiymatiga nisbati Pulmatrix, Inc. PULM|Bozor qiymatining balans qiymatiga nisbati Pheton Holdings Limited PTHL|Aptorum - Bozor kapitallashuvining balans qiymatiga nisbati|Lyra Therapeutics Inc. (LYRA) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Impact BioMedical IBO|TNFA (TNF Pharmaceuticals, Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati cbdMD Inc. YCBD|Sof aktivlarga nisbatan bozor kapitallashuvi painreform.com|Altamira Therapeutics (CYTO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati OptiNose Inc (OPTN)|Bozor kapitallashuvining balans qiymatiga nisbati PIRS (Pieris)|Procaps Group Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI: Balans qiymatiga nisbatan bozor qiymati|SLRN (ACELYRIN) - Bozor qiymatining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Kapitallashuvning sof aktivlarga nisbati